Vonicog Alfa
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB12872 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 89 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | primary release disorder of platelets | KG + DL |
| 2 | Glanzmann thrombasthenia | KG + DL |
| 3 | pseudo-von Willebrand disease | KG + DL |
| 4 | hemophilia | KG + DL |
| 5 | Scott syndrome | KG + DL |
| 6 | acquired coagulation factor deficiency | KG + DL |
| 7 | Von Willebrand disease, X-linked form | KG + DL |
| 8 | bleeding diathesis due to a collagen receptor defect | KG + DL |
| 9 | hemorrhagic disorder due to a constitutional thrombocytopenia | KG + DL |
| 10 | flood factor deficiency | KG + DL |
| 11 | hereditary thrombocytosis with transverse limb defect | KG + DL |
| 12 | familial thrombomodulin anomalies | KG + DL |
| 13 | inherited thrombophilia | KG + DL |
| 14 | small bowel Crohn disease | KG + DL |
| 15 | methylcobalamin deficiency type cblG | KG + DL |
| 16 | esophageal ulcer | KG + DL |
| 17 | gastritis | KG + DL |
| 18 | thrombotic thrombocytopenic purpura | KG + DL |
| 19 | hemorrhagic disorder due to a coagulation factors defect | KG + DL |
| 20 | inherited prekallikrein deficiency | KG + DL |
| 21 | non-syndromic esophageal malformation | KG + DL |
| 22 | esophageal leukoplakia (disease) | KG + DL |
| 23 | congenital factor V deficiency | KG + DL |
| 24 | esophageal atresia (disease) | KG + DL |
| 25 | congenital factor XI deficiency | KG + DL |
| 26 | dyskinesia of esophagus | KG + DL |
| 27 | symptomatic form of hemophilia in female carriers | KG + DL |
| 28 | platelet-type bleeding disorder | KG + DL |
| 29 | esophageal diverticulosis | KG + DL |
| 30 | Ehlers-Danlos syndrome, fibronectinemic type | KG + DL |
| 31 | esophageal tuberculosis | KG + DL |
| 32 | esophageal malformation | KG + DL |
| 33 | Tatsumi factor deficiency | KG + DL |
| 34 | fetal and neonatal alloimmune thrombocytopenia | KG + DL |
| 35 | multiple sclerosis-ichthyosis-factor VIII deficiency syndrome | KG + DL |
| 36 | venous insufficiency (disease) | KG + DL |
| 37 | C1 inhibitor deficiency | KG + DL |
| 38 | glaucoma | KG + DL |
| 39 | esophageal varices without bleeding | KG + DL |
| 40 | esophageal varices with bleeding | KG + DL |
| 41 | varicose disease | KG + DL |
| 42 | esophageal disease | KG + DL |
| 43 | congenital prothrombin deficiency | KG + DL |
| 44 | hemophilia A with vascular abnormality | KG + DL |
| 45 | thrombocytopenic purpura | KG + DL |
| 46 | serpinopathy with toxic serpin polymerization | KG + DL |
| 47 | hemorrhagic disorder due to a platelet anomaly | KG + DL |
| 48 | Evans syndrome | KG + DL |
| 49 | congenital vitamin K-dependent coagulation factors deficiency | KG + DL |
| 50 | coagulation protein disease | KG + DL |
(Showing top 50 of 89 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.